We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Reference sheet · Neuropeptides · CPC catalog code MOG-001
Full physicochemical data (sequence, molecular formula, molecular weight, CAS) is documented on the upstream certificate of analysis. Request the current lot COA from the supplier before use — values may vary between manufacturing runs.
Reference standards in the Neuropeptides class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.
Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) sits within the Neuropeptides research class (CPC reference MOG-001). Neuropeptides bind GPCRs expressed on central and peripheral neurons — modulating cAMP, calcium, and β-arrestin signaling to shape neurotransmission, network excitability, and behavior. Investigators typically incorporate Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) as a reference standard, tool ligand, or substrate in the assay contexts listed above. Radioligand binding, cAMP HTRF, calcium mobilization, and in vivo behavior assays.
Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) (CPC catalog code MOG-001) is a synthetic neuropeptide receptor ligand in the neuropeptides category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
Published and internal research programs use Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) as a reference standard in neuropeptides workflows — for example, gpcr receptor-binding and functional profiling and behavioral pharmacology (rodent models). Human clinical evidence is not established.
No. Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
In a neuropeptides workflow, Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse, rat) is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Radioligand binding, cAMP HTRF, calcium mobilization, and in vivo behavior assays.
Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.